{"id":"dantron","rwe":[{"pmid":"37682937","year":"2023","title":"Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.","finding":"","journal":"PloS one","studyType":"Clinical Study"},{"pmid":"36771157","year":"2023","title":"A Knowledge-Graph-Based Multimodal Deep Learning Framework for Identifying Drug-Drug Interactions.","finding":"","journal":"Molecules (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"35472744","year":"2022","title":"The copper(II) complex of dantron showed therapeutic effect on bacterial gill-rot disease in tilapia infected by Flavobacterium columnar.","finding":"","journal":"Journal of inorganic biochemistry","studyType":"Clinical Study"},{"pmid":"33290464","year":"2020","title":"Imaging studies of photodegradation and self-healing in anthraquinone derivative dye-doped PMMA.","finding":"","journal":"Physical chemistry chemical physics : PCCP","studyType":"Clinical Study"},{"pmid":"32851912","year":"2021","title":"In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly.","finding":"","journal":"Journal of biomolecular structure & dynamics","studyType":"Clinical Study"}],"tags":[{"label":"dantron","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Amine oxidase [flavin-containing] A","category":"target"},{"label":"MAOA","category":"gene"},{"label":"MAOB","category":"gene"},{"label":"A06AB03","category":"atc"},{"label":"Active","category":"status"},{"label":"Constipation","category":"indication"},{"label":"Napp Pharmaceuticals Ltd","category":"company"},{"label":"Cathartics","category":"pharmacology"},{"label":"Gastrointestinal Agents","category":"pharmacology"},{"label":"Mutagens","category":"pharmacology"},{"label":"Noxae","category":"pharmacology"}],"phase":"marketed","safety":{"contraindications":["Appendicitis","Gastrointestinal obstruction","Incontinence of feces","Urinary incontinence"]},"trials":[],"aliases":[],"company":"Napp Pharmaceuticals Ltd","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=dantron","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:03:53.986237+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:03:59.239437+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dantron","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:03:59.528910+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Retinoid X receptor alpha antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:04:00.656239+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL53418/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:04:00.309993+00:00"}},"allNames":"dionone","offLabel":[],"synonyms":["danthron","antrapurol","chrysazin","danthrone","dantron","diaquone","dionone","laxanorm","laxanthreen","1,8-Dihydroxyanthraquinone"],"timeline":[{"date":"1994-10-19","type":"positive","source":"DrugCentral","milestone":"UK Medicines and Healthcare Products Regulatory Agency (MHRA) approval (Napp Pharmaceuticals Ltd)"}],"approvals":[{"date":"1994-10-19","orphan":false,"company":"Napp Pharmaceuticals Ltd","regulator":"UK Medicines and Healthcare Products Regulatory Agency (MHRA)"}],"brandName":"Dionone","ecosystem":[{"indication":"Constipation","otherDrugs":[{"name":"bisacodyl","slug":"bisacodyl","company":"Braintree"},{"name":"cholic acid","slug":"cholic-acid","company":"Rtrx"},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"glycerol","slug":"glycerol","company":"B Braun"}],"globalPrevalence":null}],"mechanism":{"target":"Amine oxidase [flavin-containing] A","targets":[{"gene":"MAOA","source":"DrugCentral","target":"Amine oxidase [flavin-containing] A","protein":"Amine oxidase [flavin-containing] A"},{"gene":"MAOB","source":"DrugCentral","target":"Amine oxidase [flavin-containing] B","protein":"Amine oxidase [flavin-containing] B"}],"modality":"Small Molecule","drugClass":"dantron","explanation":"","oneSentence":"","technicalDetail":"Dionone acts as a competitive inhibitor of amine oxidase [flavin-containing] A, which is involved in the oxidative deamination of various endogenous and exogenous amines, thereby modulating the breakdown of these compounds and contributing to its laxative effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3125","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dantron","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:28:13.028237","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:04:02.045556+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"oxyphenisatine","drugSlug":"oxyphenisatine","fdaApproval":"","relationship":"same-class"},{"drugName":"bisacodyl","drugSlug":"bisacodyl","fdaApproval":"2004-05-10","relationship":"same-class"},{"drugName":"castor oil","drugSlug":"castor-oil","fdaApproval":"","relationship":"same-class"},{"drugName":"sodium picosulfate","drugSlug":"sodium-picosulfate","fdaApproval":"2012-07-16","relationship":"same-class"}],"genericName":"dantron","indications":{"approved":[{"name":"Constipation","source":"DrugCentral","snomedId":14760008,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"oxyphenisatine","brandName":"oxyphenisatine","genericName":"oxyphenisatine","approvalYear":"","relationship":"same-class"},{"drugId":"bisacodyl","brandName":"bisacodyl","genericName":"bisacodyl","approvalYear":"2004","relationship":"same-class"},{"drugId":"castor-oil","brandName":"castor oil","genericName":"castor oil","approvalYear":"","relationship":"same-class"},{"drugId":"sodium-picosulfate","brandName":"sodium picosulfate","genericName":"sodium picosulfate","approvalYear":"2012","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000179096","NDDF":"001171","UNII":"Z4XE6IBF3V","VUID":"4018988","CHEBI":"CHEBI:3682","VANDF":"4018988","INN_ID":"81","RXNORM":"22293","UMLSCUI":"C0057135","chemblId":"CHEMBL53418","ChEMBL_ID":"CHEMBL53418","KEGG_DRUG":"D07107","DRUGBANK_ID":"DB04816","PDB_CHEM_ID":" CHZ","PUBCHEM_CID":"2950","SNOMEDCT_US":"387364000","MESH_SUPPLEMENTAL_RECORD_UI":"C004315"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Napp Pharmaceuticals Ltd","relationship":"Original Developer"}],"publicationCount":11,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"A06AB03","allCodes":["A06AB03","A06AB53","A06AG03"]},"biosimilarFilings":[],"originalDeveloper":"Napp Pharmaceuticals Ltd","recentPublications":[{"date":"2023","pmid":"37682937","title":"Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.","journal":"PloS one"},{"date":"2023 Feb 3","pmid":"36771157","title":"A Knowledge-Graph-Based Multimodal Deep Learning Framework for Identifying Drug-Drug Interactions.","journal":"Molecules (Basel, Switzerland)"},{"date":"2022 Jul","pmid":"35472744","title":"The copper(II) complex of dantron showed therapeutic effect on bacterial gill-rot disease in tilapia infected by Flavobacterium columnar.","journal":"Journal of inorganic biochemistry"},{"date":"2020 Dec 23","pmid":"33290464","title":"Imaging studies of photodegradation and self-healing in anthraquinone derivative dye-doped PMMA.","journal":"Physical chemistry chemical physics : PCCP"},{"date":"2021 Nov","pmid":"32851912","title":"In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly.","journal":"Journal of biomolecular structure & dynamics"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Napp Pharmaceuticals Ltd","companyId":"napp-pharmaceuticals-ltd","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"UK Medicines and Healthcare Products Regulatory Agency (MHRA)","status":"approved","approval_date":"1994-10-19T00:00:00.000Z","mah":"Napp Pharmaceuticals Ltd","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:04:02.045556+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}